Trends in national mortality rates

This website shows time trends in mortality rates. The rates are for particular countries, ages and causes of death—and you can choose which. To begin, click one of the images at right.

Countries: Full sets of graphs are available for 40 countries, including the United Kingdom, the United States, Canada, Sweden, Australia, New Zealand, the Netherlands, Germany, Japan, France, Spain, Singapore and Italy.

Mortality rates: Most mortality rates were calculated using data from the World Health Organization (WHO). WHO is not, however, responsible for any of this site's content.

Fuente: Mortality-trends.org

About Visuals Online

General Information: The National Cancer Institute's (NCI) Visuals Online provides a range of photographs and illustrations that may help communicators of medical and public health convey meaning, describe concepts, and tell stories. The collection spans everything from biomedical, science, and patient-care related illustrations and images to portraits of present and past directors and the staff of the National Cancer Institute. Visuals Online currently provides public access to 3,021 images.

Photos and Images: NCI contracts with or buys images from professional photographers or purchases stock images. In cases where NCI sends a photographer on a public shoot, the photographer is required to get a signed release form from any subject who is recognizable to avoid invasion of privacy issues, and we do our best to obtain adequate authorization. The photographer typically does not photograph other individuals who would likely trade on their image commercially.

Use of Images: Each image or illustration included in the NCI Visuals Online Web site is labeled either "Public Domain" (free to use) or "Copyright Protected" (restricted, obtain permission before use).

Most of the images available in this library are in the public domain and are not subject to copyright restrictions. No special permission is required to use or reproduce public domain images. However, ANY reproduced images should acknowledge NCI as the originator, the NCI Web site, www.cancer.gov, as the source and/or the image creator. The source can be cited as: The Web site of the National Cancer Institute (http://www.cancer.gov).

Some images are copyright protected. If an image is marked as copyright protected, you must contact the rights holder to obtain permission to reuse. Contact information for reuse is posted at the bottom of the details page for each copyrighted image. Permissions, including credit line and/or fees for use of privately owned material, must be negotiated directly with the private-sector contractor, independent of the government. NCI does not have the authority to grant usage for any copyrighted images in this library.

Fuente: VisualOnLine.Cancer.Org

Surgical Pathology Criteria is focused on the presentation of useful diagnostic, grading and staging criteria in an accessible format.

The site is designed for use by pathologists in practice
Enter via either of two methods:

• Keyword Search - a free text search of the site (box at top right)
• Diseases and Disorders by Section

Fuente: SurgicalPathologyCriteria.Stanford.edu

Declaración de Ginebra sobre el Cuidado Prenatal

“Cómo médicos e investigadores, declaramos que el término “ Incompatible con la vida” no es un diagnostico médico y no debería ser empleado para describir niños no nacidos que puedan tener condiciones que limiten su tiempo de vida”.

Reconocemos que no existe necesidad médica de finalizar esos embarazos más que con una madre saludable y sana.

Apoyamos totalmente el desarrollo prenatal de servicios de hospedaje para las familias a las que han comunicado que su hijo no nacido puede que no viva por mucho tiempo en el vientre maternal o después del nacimiento".

La Declaración está disponible aquí here

Y la firma del formulario aquí here

El lanzamiento oficial de la declaración tendrá lugar en Naciones Unidas en Ginebra el 11 de marzo.

Agradeciendole de antemano su atención prestada,

Saludos cordiales

Prof Eamon O'Dwyer
Chairperson to the Committee on Excellence in Maternal Healthcare
URL: www.dublindeclaration.com

Healthy living made possible by pathologists

Michael J. Misialek, MD
Pathologist

Fuente: Pathreport.org

Prevenga el Cáncer de Cuello Uterino

Fuente:Tweet de @CDC_Cancer

Blog, Newsletters, Reviewers, Updates, CME, Webinars, Feature Page, FAQ, Testimonials, Jobs, Fellowships, Conferences, Books, Cases, Advertise, Buyers Guide, New Products, Surveys.

PathologyOutlines.com

Join us for the 30th International Papillomavirus Conference & Clinical and Public Health Workshops (HPV 2015) that will be held September 17-21 in Lisbon, Portugal. This year we will focus on HPV and Globalization, exploring new worlds in research as well as new proposals to reduce inequities in global health.

Patrocinado por Nikon en este sitio encontrará Galerías de Imágenes, Tutoriales relacionado con la microscopía, artículos y otro material iconográfico útil en docencia.

URL: http://www.microscopyu.com

http://www.cap.org/web/home/resources/cancer-reporting-tools/cancer-prot...

___
Admin Eusalud

FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV.

Comunicado: La Administración de Alimentos y Medicamentos de los Estados Unidos (FDA por su siglas en inglés) aprobó hoy Gardasil 9 (Vacuna nanovalente recombinante para el virus del papiloma humano) para la prevención de ciertas enfermedades causadas por nueve tipos de virus del papiloma humano (VPH). Gardasil 9 protege contra nueve tipos de VPH, cinco tipos más de VPH que Gardasil (previamente aprobada por la FDA), y tiene el potencial de prevenir aproximadamente el 90 por ciento del cáncer del cuello uterino, de la vulva, vaginal y anal.

Gardasil 9 es una vacuna aprobada para su uso en mujeres entre las edades de 9 a 26 años y en hombres de entre 9 a 15 años. Está aprobada para la prevención del cáncer de cérvix, de la vulva, vaginal y anal causado por los tipos de VPH 16, 18, 31, 33, 45, 52 y 58, y para la prevención de las verrugas genitales causadas por los tipos de VPH 6 o 11. Gardasil 9 añade protección contra cinco tipos adicionales de VPH-31, 33, 45, 52 y 58- los que causan aproximadamente el 20 por ciento del cáncer de cuello uterino y no están cubiertos por vacunas contra el VPH previamente aprobadas por la FDA.

"La vacunación es una medida de salud pública de importancia crítica para reducir el riesgo de la mayoría de los cánceres del cuello uterino, genital y anal causados por el VPH", dijo la doctora Karen Midthun, MD, directora del Centro para la Evaluación e Investigación de Productos Biológicos de la FDA. "La aprobación de Gardasil 9 proporciona una mayor protección contra los cánceres relacionados al VPH”.

January Is Cervical Cancer Awareness Month

The most important thing you can do to help prevent cervical cancer is to get screened regularly starting at age 21.

Cervical cancer is highly preventable with regular screening tests and appropriate follow-up care. It also can be cured when found early and treated. Cervical cancer is almost always caused by the human papillomavirus (HPV). Vaccines are available to protect against the types of HPV that most often cause cervical cancer.

Fuente: Tweet de @CDCSTD https://twitter.com/CDCSTD/status/551981937737224192?s=09

PRODUCCIÓN CIENTÍFICA DE LA REVISTA ELECTRÓNICA DE BIOMEDICINA. ESTUDIO BIBLIOMÉTRICO 2003-2012. - Emergencias/CASMU-IAMPP y Emergencia Uno. Montevideo. Uruguay. Universidad de Ciencias Médicas "Dr. Raúl Dorticós Torrado", Cienfuegos; Instituto Superior de Ciencias Médicas "Serafín Ruiz de Zarate", Santa Clara, Villa Clara. Cuba. [Rev Electron Biomed]

CONSIDERACIONES SOBRE LA INFLUENZA: VIRUS Y VACUNAS - EDITORIAL /EDITORIAL. Profesor Honorario de la Facultad de Ciencias Médicas y Miembro del Consejo de Investigaciones de la Universidad Nacional de Rosario. Rosario. Argentina. [Rev Electron Biomed]

Feliz Navidad y próspero año nuevo 2015.